Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:CASNumber |
1391640-56-0
|
| gptkbp:chemicalClass |
triazole
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Pulmocide_Ltd
|
| gptkbp:form |
nebulized solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
PC945
|
| gptkbp:indication |
treatment of pulmonary aspergillosis
|
| gptkbp:mechanismOfAction |
inhibits fungal CYP51 enzyme
|
| gptkbp:organism |
gptkb:Aspergillus_fumigatus
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:bfsParent |
gptkb:Pulmocide
|
| gptkbp:bfsLayer |
7
|